latest news releases from the newsroom
New Clinical Data Further Support Applicability of Epigenomics' Lead Biomarker For Colorectal Cancer Screening
BERLIN and SEATTLE, May 21, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) and Prof. Dr. Matthias Ebert, Professor of Clinical and Molecular Gastroenterology at the University Hospital of the Technical University of Munich, Germany, yesterday presented new data supportive of Epigenomics Colorectal Cancer Screening Test Development Program at the Digestive Disease Week 2007 in Washington D.C., U.S.A. The results were a product of collaborative clinical studies with Epigenomics, a molecular diagnostics company developing cancer tests based on DNA methylation.
Golden Ocean Group Limited
Golden Ocean Group Limited: Long Term Time Charter Contracts
HAMILTON, Bermuda, May 21, 2007 (PRIME NEWSWIRE) -- Golden Ocean Group Limited ("Golden Ocean") is pleased to advise that the Company has fixed out on time charter three Capesize Bulkers from Daehan Shipbuilding Co., Ltd., South Korea. Each vessel is committed for a period of five years and will be delivered to their respective Charterer's between August 2008 and March 2009. The time charter rates are $48,000 per day net for the first vessel, $46,000 per day net for the second vessel and $43,800 per day net for the third vessel. The vessels will commence their charter immediately after delivery from the yard in August 2008, December 2008 and March 2009 respectively. The first Capesize vessel in the newbuilding program from Daehan with delivery in May 2008 remains open at this stage.